Keyuan Huaji Biotech
科源华济
Keyuan Huaji Biotech
Biotech/Healthcare
Keyuan Huaji is a biopharmaceutical R&D company primarily engaged in the R&D, production, and sale of innovative drugs based on cell immunotherapy and nanomedicine technologies, used to treat solid tumors via tumor-infiltrating lymphocyte (TIL) therapy and other conditions. The company is committed…
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.